An unusual presentation of a common infection

Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma

(2011) S. D. Dojcinov et al.   BLOOD

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

(2011) J. I. Cohen et al.   BLOOD

Successful treatment with rituximab and donor lymphocyte infusions for fulminant EBV-associated lymphoproliferative disorder that developed 14 years after unrelated BMT

(2011) T Kawaguchi et al.   BONE MARROW TRANSPLANTATION

Epstein–Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment

(2010) Mattias Magnusson et al.   RHEUMATOLOGY

Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008

(2009) J. I. Cohen et al.   ANNALS OF ONCOLOGY

Girls homozygous for an IL-2–inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation

(2009) Kirsten Huck et al.   JOURNAL OF CLINICAL INVESTIGATION

The Spectrum of Epstein-Barr Virus-Associated Lymphoproliferative Disease in Korea: Incidence of Disease Entities by Age Groups

(2008) Eun-Yoon Cho et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T-LPD

(2008) Koichi Ohshima et al.   PATHOLOGY INTERNATIONAL